A genome‐wide investigation including individuals with breast, colorectal, or ovarian cancer, alongside a comprehensive study on a group of 100 breast cancer patients, identified mutations in NE proteins known as nesprins.27, 28. This evidence concerns the gene ELANE and breast carcinoma.